Global Fetal Bovine Serum Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Fetal Bovine Serum Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin and clotting factors, but containing a large number of nutritional and macromolecular factors essential for cell growth. Bovine serum albumin is the major component of FBS.
Fetal Bovine Serum report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fetal Bovine Serum market is projected to reach US$ 1145.7 million in 2034, increasing from US$ 968.9 million in 2022, with the CAGR of 0.8% during the period of 2024 to 2034. Demand from Scientific Research and Industrial Production are the major drivers for the industry.
Global key players of fetal bovine serum include Thermo Fisher, Merck, Cytiva, etc. The top three players hold a share about 78%. The global fetal bovine serum products are mainly produced in Europe and United States, they occupied for a share over 80%. North America is the largest market, has a share about 39%, followed by Europe and Asia Pacific, with share 37% and 20%, separately.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fetal Bovine Serum market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Thermo Fisher
Merck
Cytiva
Biowest
Moregate BioTech
ExCell Bio
Internegocios
Tissue Culture Biologicals
Gemini
Corning
Biological Industries
VWR
Bovogen
R&D Systems
Seroxlab
Animal Technologies
RMBIO
Bio Nutrientes Brasil
Serana
WISENT
PAN-Biotech
Zhejiang Tianhang Biotechnology
Lanzhou Minhai
Peak Serum
Jin Yuan Kang
Segment by Type
USA-sourced
South America-sourced
Australia-sourced
Others
Scientific Research
Industrial Production
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Fetal Bovine Serum market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Fetal Bovine Serum, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Fetal Bovine Serum industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Fetal Bovine Serum in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Fetal Bovine Serum introduction, etc. Fetal Bovine Serum Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Fetal Bovine Serum market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Fetal Bovine Serum report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fetal Bovine Serum market is projected to reach US$ 1145.7 million in 2034, increasing from US$ 968.9 million in 2022, with the CAGR of 0.8% during the period of 2024 to 2034. Demand from Scientific Research and Industrial Production are the major drivers for the industry.
Global key players of fetal bovine serum include Thermo Fisher, Merck, Cytiva, etc. The top three players hold a share about 78%. The global fetal bovine serum products are mainly produced in Europe and United States, they occupied for a share over 80%. North America is the largest market, has a share about 39%, followed by Europe and Asia Pacific, with share 37% and 20%, separately.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fetal Bovine Serum market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher
Merck
Cytiva
Biowest
Moregate BioTech
ExCell Bio
Internegocios
Tissue Culture Biologicals
Gemini
Corning
Biological Industries
VWR
Bovogen
R&D Systems
Seroxlab
Animal Technologies
RMBIO
Bio Nutrientes Brasil
Serana
WISENT
PAN-Biotech
Zhejiang Tianhang Biotechnology
Lanzhou Minhai
Peak Serum
Jin Yuan Kang
Segment by Type
USA-sourced
South America-sourced
Australia-sourced
Others
Segment by Application
Scientific Research
Industrial Production
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Fetal Bovine Serum market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Fetal Bovine Serum, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Fetal Bovine Serum industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Fetal Bovine Serum in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Fetal Bovine Serum introduction, etc. Fetal Bovine Serum Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Fetal Bovine Serum market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.